DIVISION OF CANCER SURVIVAL PROJECT
· Mitigation of Kidney Injury from Chemotherapy
Many cancer treatments have side-effects including acute kidney injury. Administration of Company Product 3 days prior to the start of Cisplatin treatment mitigates harm to the kidneys.
· Faster Surgical Healing after Mastectomy
Many breast cancer patients need radiation therapy after surgery. Unfortunately, radiation can impede the surgical wound healing process. Administration of the Company Product will benefit such patients.
· Control over Bleeding from Low Platelet Count after Cancer Treatment
The Company Product has an active ingredient called Fibrinogen-coated Albumin Sphere (FAS). Just like "hamburger helper" is not meat but can taste like meat and is cheaper, FAS can help the patient stop bleeding by forming co-aggregates with the patient's own activated platelets at a wound site without causing random clots.
· Reduce Bleeding for Patients with Platelet-Transfusion Refractoriness
Patients with low platelet count tend to bleed. They are often transfused with platelets from donors. Unfortunately, platelet transfusions can lead to a condition called "platelet-transfusion refractoriness" meaning the body destroys the infused platelets. The Company Product is effective even under such a dire condition because it cannot be destroyed by anti-platelet antibodies.